Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bile duct cancer, Biliary tree cancers, Gallbladder cancer
Closed
Phase 3
This trial is looking at adding a drug called rilvegostomig to chemotherapy for bile duct and gallbladder cancer.
It is for people who have had surgery to completely remove their cancer with the aim to cure.
You pronounce rilvegostomig as ril–veh–gost-oh-mig.
Recruitment start: 1 May 2024
Recruitment end: 31 July 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Roopinder Gillmore
AstraZeneca
Last reviewed: 09 Dec 2025
CRUK internal database number: 20026